menu
    • menu

    Company profile for Neurogastrx

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with ...
    We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with chronic and debilitating GI disorders that are not adequately controlled.Gastroparesis is a common complication of diabetes, but there is also a significant idiopathic population

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeurogastrxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 Unicorn Park Drive Woburn, MA 01801
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neurogastrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neurogastrx-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neurogastrx Reveals NG101 Ph2 Study Shows Major Reductions
    Neurogastrx Reveals NG101 Ph2 Study Shows Major Reductions

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183664/0/en/Neurogastrx-Announces-NG101-Phase-2-Clinical-Study-Demonstrating-Significant-Reductions-in-Nausea-and-Vomiting-Induced-by-GLP-1-Receptor-Agonist-Semaglutide.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Neurogastrx To Present NG101 Data Reducing GLP-1 Related Nausea
    Neurogastrx To Present NG101 Data Reducing GLP-1 Related Nausea

    07 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/07/3162548/0/en/Neurogastrx-to-Present-Proof-of-Concept-Clinical-Data-on-Oral-Candidate-NG101-to-Reduce-Nausea-Vomiting-Associated-with-GLP-1-Agonists-at-ObesityWeek.html

    GLOBENEWSWIRE
    07 Oct 2025
    Share Share
    Neurogastrx Announces Positive Data For NG101 In Reducing Nausea
    Neurogastrx Announces Positive Data For NG101 In Reducing Nausea

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2963836/0/en/Neurogastrx-Announces-Positive-Proof-of-Concept-Data-for-Investigational-Drug-NG101-in-Reducing-Nausea-and-Vomiting-Associated-with-the-Administration-of-GLP-1-Agonist-Medication.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Daewoong Regaining Rights to Fexuprazan in the USA and Canada
    Daewoong Regaining Rights to Fexuprazan in the USA and Canada

    05 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-regaining-rights-to-fexuprazan-in-the-united-states-and-canada-upon-termination-of-license-agreement-with-neurogastrx-301841938.html

    PR NEWSWIRE
    05 Jun 2023
    Share Share
    Neurogastrx assembles ex-Ironwood team with $60M
    Neurogastrx assembles ex-Ironwood team with $60M

    27 Aug 2021

    // Kyle LaHucik FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/neurogastrx-served-platter-60m-for-phase-2-3-gi-drugs-adds-cmo-cfo-and-cbo

    Kyle LaHucik FIERCE BIOTECH
    27 Aug 2021
    Share Share
    After pandemic delay & a South Korean deal, Boston-area biotech raises Series B
    After pandemic delay & a South Korean deal, Boston-area biotech raises Series B

    26 Aug 2021

    // Jason Mast ENDPTS

    https://endpts.com/after-pandemic-delay-and-a-south-korean-deal-boston-area-biotech-raises-series-b-with-sights-on-ipo/

    Jason Mast ENDPTS
    26 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search